Skip to main content

Luís Gros Subias

Institutions of which they are part

Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Luís Gros Subias

Institutions of which they are part

Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

Red Temática de Investigación Cooperativa en Cáncer - RTICC

IP: Josep Sánchez de Toledo Codina
Collaborators: Soledad Gallego Melcón, Luís Gros Subias, Pablo Velasco Puyó, Aroa Soriano Fernández, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Constantino Sábado Álvarez, Anna Llort Sales, Laura Alonso Garcia, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 186750
Reference: RD12/0036/0016
Duration: 01/01/2013 - 30/06/2017

Calidad de vida en pacientes pediátricos afectos de tumores en el Sistema Nervioso Central. Papel modulador del as secuelas y de las estrategias de afrontamiento de los padres

IP: -
Collaborators: Luís Gros Subias, Constantino Sábado Álvarez, Anna Llort Sales
Funding agency: Asociación Española Contra el Cáncer
Funding: 18000
Reference: AECC 6/2008
Duration: 22/01/2009 - 21/01/2011

Identificación de nuevas dianas terapéuticas en el rabdomiosarcoma: efectos de la silenciación de las vías de señalización celular de NOTCH, Hedgehog y RAS en esta neoplasia

IP: Soledad Gallego Melcón
Collaborators: Luís Gros Subias, Constantino Sábado Álvarez, Josep Roma Castanyer
Funding agency: Asociación Española Contra el Cáncer
Funding: 18000
Reference: AECC_CAT_01_2007
Duration: 21/01/2008 - 20/01/2010

RTICC - Red Temática de Investigación cooperativa de cáncer

IP: Josep Sánchez de Toledo Codina
Collaborators: Soledad Gallego Melcón, Luís Gros Subias, Maria Cristina Díaz de Heredia Rubio, Miguel Segura Ginard, Constantino Sábado Álvarez, Anna Llort Sales, Josep Roma Castanyer
Funding agency: Instituto de Salud Carlos III
Funding: 51990
Reference: RD06/0020/1021
Duration: 01/01/2008 - 31/12/2014

Related news

The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.

In-depth knowledge of tumours helps identify specific alterations and enables the provision of targeted therapies for each patient.

The charitable initiative created in honor of Pol is supporting a research project aimed at identifying therapeutic targets to treat a rare type of leukemia.

Related professionals

Picos Pouso, Roberto

Picos Pouso, Roberto

Shock, Organ Dysfunction and Resuscitation
Read more
Rello Saltor, Victoria

Rello Saltor, Victoria

Predoctoral researcher
Infection and immunity in pediatric patients
Read more
Navarro Alonso, Marta

Navarro Alonso, Marta

Infectious Diseases
Read more
Fernandez Torrelles, Sara

Fernandez Torrelles, Sara

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.